An Effective Combination Therapy: Neural Therapy Intensifies Efficacy of Pleo™-Muc (Mucokehl)

by © Copyright by Semmelweis-Institut GmbH · 27316 Hoya · Germany | Mar 31, 2012
It happens, that Pleo™Muc suddenly produces reduced healing reactions after it has shown a good efficacy at first. Thus, there is not only a different success with different patients, it also turns out, that the same patient reacts very well in certain periods and then at other days he reacts only a little to the remedy Certainly, this appearance is based an the influence of the personal biorhythm.

It happens, that Pleo™Muc suddenly produces reduced healing reactions after it has shown a good efficacy at first. Thus, there is not only a different success with different patients, it also turns out, that the same patient reacts very well in certain periods and then at other days he reacts only a little to the remedy Certainly, this appearance is based an the influence of the personal biorhythm.

Not at all is this a question of quality of this well-established preparation of which constant quality is guaranteed by the manufacturing process. Rather we must look for the reason for different reactions after the use of Pleo™Muc in the changeable vegetative fundamental basis of the patient. It is known that this is influenced by many different conditions, as for example by a change in the weather.

Neural Therapy Improves Reaction

The overstimulation, which increases from year to year, causes a dystonia of the nerves, which often has to be improved before starting treatment with Pleo™Muc. Dr. Smend, Hamburg, Germany has cured hundreds of seemingly hopeless cancer victims only with Pleo™Muc. He mainly deals with vegetative patients with a normal tonus. In the meantime those patients have become rarely, especially among the youth.

Against that neural therapy should be used additionally in order to give Pleo™Muc a wide target, through a euthenic starting point in the patient for removal of the last causes of chronic diseases. At this moment it is not possible to give a scientifically satisfactory explanation as to why a mistension of the nerves is responsible for this difficulty in locating and healing disease. However, it has to be referred to the literature about neural therapy by Huneke as well as the book by Fritz A. Popp So könnte Krebs entstehen.

The experience shows definitely that it is possible to achieve a change in a patient's reaction mode by an injection of an anesthetic agent into "sources of infection" and "trouble fields" as well as by treatment of spinal syndromes, for example, frequently relapsing inflammations of certain organs (for example spring and autumnal gastritis). Every two to three months some diseased persons are afflicted by irido-cyclitis. For example, the vegetative mistension in the nerves of the eye only needs an additional impulse and the inflammation is already triggered.

If now this mistension of the nerves becomes more and more intensive, finally, the time comes where even a momentary sedation cannot be achieved. The chronic disease continues to exist, and often it progresses. In such a situation we can not prevent the appearance of disease relapses only by using Pleo™Muc. However, if the affected eye is, for example, infiltrated ret-robulbarly according to Huneke, a fast healing follows. Here, Pleo™Muc and the neural therapeutic agent can be mixed.

Frequently Appearing Infections Give Hints

The disease development of approx. 50 percent of diseased persons can be calmed during therapy only with Pleo™Muc and thus without a neural-therapeutic treatment in the area where the problem lies. However, in the case of infections and angina, which appeared frequently in the past, it is recommended to inject the tonsil poles with 0.5 ml neural therapeutic agent from the beginning; appendicitis scars have to be treated exactly the same. The progress of disease shows very quickly, whether a neural therapy should be used with the most different chronic diseases.

Naturally, there are patients whose neurodystonia does not have any influence on the treatment success with Pleo™Muc at certain organs. An exact observation of the disease course also gives an immediate clarification. Skincancers, which expand extensively (for example, Paget), can be suppressed with neural therapeutic agent -weals according to Varro at a distance of approx. 1 cm, 6 to 8 injections per visit in fact, which are repeated every eight days. Easily accessible tumors of any kind can be field injected with 1 to 2 ml anesthetic agents per week. Otherwise, the lymph tracts responsible for the tumor area should be infiltrated.

With such a preparation, hindrances no longer exist concerning the effectiveness of the remedyPleo™Muc. Depending on severity of disease, 1 ml of the dilution 5X or 6X can be injected per week.Pleo™Muc 5X can be administered in case of thrombosis, Ulcus crusis and metabolic diseases. Summarized it can be said, that for increasing of its effectiveness in the mentioned casesPleo™Muc should be used together with a neural therapeutic agent as a mixed injection at acupuncture points as well as paravertebrally.

First published into the German language in the SANUM-POST magazin, into the English language in the Explore magazine, USA
© Copyright by Semmelweis-Institut GmbH · 27316 Hoya · Germany


Leave a comment